Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr HIV/AIDS Rep. 2011 Sep;8(3):192-9. doi: 10.1007/s11904-011-0084-6.

See-and-treat approaches to cervical cancer prevention for HIV-infected women.

Author information

1
University of Alabama at Birmingham School of Medicine, USA. Carla.Chibwesha@cidrz.org

Abstract

Cervical cancer remains the second commonest cancer among women worldwide, and more than 85% of the global burden of this disease occurs in the developing world. HIV-infected women have a higher likelihood of developing persistent high-risk human papillomavirus (HPV) infection, precancer, and invasive cervical cancer than seronegative women. Although highly effective primary and secondary prevention strategies are currently available, they remain inaccessible to the vast majority of women. Because of their simplicity and affordability, see-and-treat cervical cancer screening modalities have the potential to substantially improve women's access to cancer prevention, as well as to create much needed infrastructure for future molecular-based cervical screening and HPV vaccination programs. Additional data addressing the effectiveness of see-and-treat approaches for HIV-infected women are urgently needed. Studies informing best practice guidelines on when to start, when to stop, and how frequently to screen HIV-infected women within the see-and-treat paradigm would be of great value.

PMID:
21706187
DOI:
10.1007/s11904-011-0084-6
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center